List of medicines in India for treatment:

Chemotherapy Follicular Lymphoma Lymphoma

Alternative to Gazyva in India

The best equivalent of Gazyva in India called Viraferon. Analogue has exactly the same treatment option
You can buy Viraferon (alternative to Gazyva) in pharmacies of India.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Where to buy

Gazyva

Australia

Ingredients

Obinutuzumab

Treatment option

Lymphoma

Follicular Lymphoma

Chemotherapy

Pharmacological group

instruction

equal

Viraferon

50% conformity

India

Ingredients

Interferon Alfa-2b

Treatment option equal

Lymphoma

Follicular Lymphoma

Chemotherapy

Pharmacological group

Where to buy Gazyva or alternative in India

To buy Gazyva or its alternatives in India, we recommend to contact your nearest pharmacy. Call the pharmacy using the number on the map, to find out if Gazyva is in stock. Remember to ask the pharmacist about the price of the medicine and the requirement to provide a prescription, many medicines in India are sold strictly according to the doctor's prescription. Show pharmacy near me.

Show pharmacy near me

Pillintrip.com is not a pharmacy!

Other analogues

Name	Ingredients	Treatment option	Pharmacological group
Viraferon				50%
Celestone				30%
Adcon				30%
AF				30%
Alfa				30%
Aprecap				30%
Arzi				30%
Betagel				30%
Betamil				30%
Betnelan				30%
Betnesol Forte				30%
Bleocel				30%
Bortrac				30%
Cardia				30%
Cresp				30%
Dacarex				30%
Depomax				30%
Dexocan				30%
Dexona(CORTICOSTEROIDS)				30%
Diprovate				30%
Doran-O				30%
Emefilm				30%
Emenil				30%
Emeset				30%
Emetron				30%
Emitus				30%
Eterna				30%
Ethyol				30%
Eudyna				30%
Flucina				30%
Flucos				30%
Fluzole				30%
Fluzon				30%
Forcan				30%
Fungicon				30%
Funnie				30%
Grafeel				30%
Granexa				30%
Holoxan				30%
ISV				30%
Kidpred				30%
Leukeran				30%
Lomustine				30%
Lupus				30%
Lycor				30%
Lycortin-S				30%
Mitocin				30%
Mustin				30%
Nauset				30%
Nuforce				30%

Equivalent of Gazyva found in:

Medicine equivalents methodology